< Back | ||||||
Liaoyang Sunny Pharmaceutical Co.,Ltd | ||||||
About this company : The company possesses rich technology、advanced production facilities and perfect test measures,and developed more than ten high-tech products.lt is the first company to pass the quality certification system of ISO9001:2000 in the profession. The company has won the support and trust from the customers due to its good reputation,reliable quality and the first class service after sale.Thus the products are found everywhere in China.Furthermore they have been exported to dozens of countries in Eurasia.. The main products made in the company are as follows;Tubular separator,Cup type precipitation centrifuge.3-point settlement centrifuge,3-point filtering centrfuge and various centrfugal equipments, among which the tubular separator type is the "first"excellent and superior product.This machine can meet the requirements of GMP certification.And centrfugal equipments for various materials can be made for different users. | ||||||
Contact : Zhang Huiyu, Sale Manager | ||||||
Headquarters : No12-5Western Fifth Street, LIAOYANG, LIAONING , 111000, China | ||||||
Phone : 86-419-2527111, Fax : 86-419-2527111 | ||||||
Website : Log on to trade instantly , Email : Log on to trade instantly | ||||||
tubular separator GQLB-105 Type GFXB105 is one kind of tubular separator. This machine is the improved one on the base of the original separator and through experiment again and again.GFXB105 can be extensively used in separating blood plasma and cell of human being、pig、cow、sheep and chicken etc. The main feature of it is the high yield and the rate of broken blood cell can be reduced to the lowest extent. The contact parts between the separator and materials are made of stainless steel, which can meet the requirements of medicine production industry. | ||||||
> Add to cart | ||||||
Know-How | Trading Precaution | Phishing Alerts | SOAOnDemand! | VAR 360 | RSS Feed | ||
Copyright © 2024 MarginUp All Rights Reserved. MarginUp User Agreement and Privacy Policy. |
||